Charged mass labeling system

US12055550B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12055550-B2
Application numberUS-202117342804-A
CountryUS
Kind codeB2
Filing dateJun 9, 2021
Priority dateJan 22, 2016
Publication dateAug 6, 2024
Grant dateAug 6, 2024

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The invention generally relates to charged mass label compositions and methods of use thereof for detecting a target analyte in a sample. In certain aspects, the invention provides a charged mass label composition including an affinity reagent, and a mass label precursor bound to the affinity reagent. The mass label precursor includes a label binding unit and a mass label. The label binding unit reversibly binds the mass label to the affinity reagent. The mass label includes a charge unit and a mass label unit having a pre-defined mass-to-charge-value in a mass spectrum.

First claim

Opening claim text (preview).

What is claimed is: 1. A method for detecting a target analyte in a sample, the method comprising: introducing a charged mass label composition to a sample comprising a target analyte, wherein the charged mass label composition comprises an affinity reagent; and a mass label precursor bound to the affinity reagent, wherein the mass label precursor comprises a label binding unit and a mass label, the label binding unit reversibly binding the mass label to the affinity reagent, wherein the mass label comprises a charge unit chemically coupled to a mass label unit, wherein the mass label unit is neutral and has a pre-defined mass-to-charge-value in a mass spectrum, and wherein upon ionization, the charge unit releases from the mass label unit and the mass label unit is detectable in the mass spectrum due to the mass label unit having the pre-defined mass-to-charge-value in a mass spectrum; incubating the sample and the charged mass label composition so that the charged mass label composition binds the target analyte via an interaction between the affinity reagent of the charged mass label composition and the target analyte; releasing the mass label from the affinity reagent by breaking one or more bonds of the label binding unit; ionizing the mass label; and detecting the ionized mass label and/or fragments thereof in a mass spectrometer, thereby detecting the target analyte in the sample. 2. The method according to claim 1 , wherein the sample is a biological sample. 3. The method according to claim 2 , wherein the target analyte is a target biological molecule. 4. The method according to claim 3 , wherein the target biological molecule is a biomarker related to a disease. 5. The method according to claim 4 , wherein the disease is cancer. 6. The method according to claim 1 , further comprising quantifying the ionized mass label and/or fragments thereof, thereby quantifying the target analyte in the sample. 7. The charged mass label composition according to claim 1 , wherein the pre-defined mass-to-charge-value in the mass spectrum of the mass label or one or more fragments of the mass label is different from background mass-to-charge-values in the mass spectrum. 8. The charged mass label composition according to claim 1 , wherein the label binding unit comprises a reversible bond. 9. The charged mass label composition according to claim 8 , wherein the reversible bond comprises an acetal or ketal bond.

Assignees

Inventors

Classifications

  • for cancer · CPC title

  • involving oncogenic proteins · CPC title

  • Chemical aspects of mass spectrometric analysis of biological material · CPC title

  • Production of immunochemical test materials · CPC title

  • Labels used in chemical analysis of biological material · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12055550B2 cover?
The invention generally relates to charged mass label compositions and methods of use thereof for detecting a target analyte in a sample. In certain aspects, the invention provides a charged mass label composition including an affinity reagent, and a mass label precursor bound to the affinity reagent. The mass label precursor includes a label binding unit and a mass label. The label binding uni…
Who is the assignee on this patent?
Purdue Research Foundation
What technology area does this patent fall under?
Primary CPC classification G01N33/6848. Mapped technology areas include Physics.
When was this patent published?
Publication date Tue Aug 06 2024 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).